HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Three-year follow-up of a girl with chronic paroxysmal hemicrania.

Abstract
This is a follow-up report of a girl, 5 years 4 months old, with classic symptoms of chronic paroxysmal hemicrania from the age of 2 years 3 months who had a complete response to indomethacin therapy. The patient suffered from frequent episodes of severe unilateral headaches for 1 year and 10 months before the diagnosis of chronic paroxysmal hemicrania was established. Indomethacin treatment lasted for 2 years and 6 months. During the first year of treatment, several doses of indomethacin were missed, which was followed by immediate return of hemicrania episodes and then quick resolution of symptoms after administration of indomethacin. After 2 years and 6 months of treatment, the parents missed the treatment for 1 week and the episodes did not recur. The treatment was discontinued. The patient was free from pain and off the medication 1 year later.
AuthorsInga Talvik, Aleksandr Peet, Tiina Talvik
JournalPediatric neurology (Pediatr Neurol) Vol. 40 Issue 1 Pg. 68-9 (Jan 2009) ISSN: 0887-8994 [Print] United States
PMID19068259 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Indomethacin
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Follow-Up Studies
  • Headache (drug therapy, physiopathology)
  • Humans
  • Indomethacin (administration & dosage, therapeutic use)
  • Paroxysmal Hemicrania (diagnosis, drug therapy, physiopathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: